Cubist Systematic Strategies’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-275
Closed -$21K 3892
2023
Q2
$21K Buy
+275
New +$22.2K ﹤0.01% 3178
2022
Q4
Sell
-2,332
Closed -$602K 4590
2022
Q3
$602K Buy
2,332
+2,282
+4,564% +$663K ﹤0.01% 3024
2022
Q2
$9K Sell
50
-241
-83% -$23K ﹤0.01% 4277
2022
Q1
$29K Sell
291
-733
-72% -$94.1K ﹤0.01% 3445
2021
Q4
$167K Buy
1,024
+937
+1,077% +$206K ﹤0.01% 3085
2021
Q3
$24K Sell
87
-145
-63% -$44.3K ﹤0.01% 2880
2021
Q2
$92K Sell
232
-91
-28% -$42.5K ﹤0.01% 2720
2021
Q1
$174K Sell
323
-8
-2% -$4.98K ﹤0.01% 2521
2020
Q4
$125K Sell
331
-128
-28% -$50.9K ﹤0.01% 2372
2020
Q3
$173K Buy
459
+390
+565% +$172K ﹤0.01% 2170
2020
Q2
$34K Sell
69
-332
-83% -$148K ﹤0.01% 2293
2020
Q1
$147K Buy
+401
New +$208K ﹤0.01% 1815
2019
Q3
Sell
-645
Closed -$564K 2474
2019
Q2
$564K Buy
+645
New +$444K 0.01% 1403
2017
Q2
Sell
-79
Closed -$75K 1873
2017
Q1
$75K Buy
+79
New +$73.6K 0.01% 1432
2016
Q3
Sell
-139
Closed -$114K 1873
2016
Q2
$114K Buy
+139
New +$151K 0.01% 1484
2015
Q3
Sell
-19
Closed -$35K 2016
2015
Q2
$35K Sell
19
-73
-79% -$113K ﹤0.01% 1730
2015
Q1
$149K Buy
+92
New +$136K 0.01% 1605

Other funds holding TCRT

Cubist Systematic Strategies's TCRT Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 275 shares — an estimated $21K sold.

Cubist Systematic Strategies first reported a position in TCRT in Q1 2015 and held it in 17 quarters. The position peaked at $602K in Q3 2022. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 275 Alaunos Therapeutics shares in Q3 2023, an estimated $21K.
  • Cubist Systematic Strategies first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 17 quarters.
  • Cubist Systematic Strategies's Alaunos Therapeutics position peaked at $602K in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.